Catalent Wins Scottish Engineering Vice President Award for Excellence
SOMERSET, N.J. – October 1, 2020— Catalent, a global leader in clinical supply services, has announced that its clinical supply site in Bathgate, West Lothian has won Scottish Engineering’s ‘Vice President Award 2020,’ recognising its continuous improvement programme in core values including “patient first, customer dedication, people, innovation, integrity and excellence.”
The award was presented to Catalent’s General Manager of the Bathgate facility, Dianne Coughlan, at an official ceremony at Scottish Engineering’s Glasgow headquarters on Sept. 18.
Speaking at the ceremony, Ms. Coughlan commented, “We are delighted to receive this award from Scottish Engineering, which assesses key performance indicators in areas including safety, quality, delivery and costs.” She added, “Our Bathgate facility plays a key role in Catalent’s global Clinical Supply Services network and we are proud of the work we do in helping to bring important new medicines to patients.”
Paul Sheerin, Chief Executive of Scottish Engineering commented, “All of our Award winners have displayed resilience, innovation and a willingness to embrace change to drive their business forward, but Catalent also stood out for their use of lean and agile approaches to continuous improvement to meet their ‘patient first’ mindset.”
Primarily involved in the production, packaging, storage and global distribution of patient kits for clinical trials, the 141,000-square-foot (13,100-sq.-metre) Bathgate facility’s current workforce exceeds 200, a headcount that has grown significantly over the last few years.
Customers of Catalent’s Bathgate site include large, global pharmaceutical organisations, as well as smaller Scottish companies that make up one of Europe’s largest life science clusters.
The Bathgate site was originally purpose-built as a clinical packaging and logistics facility and was officially opened by Quintiles in Sept 1997, and since then it has expanded significantly to meet customer needs prior to becoming part of the Catalent network in 2007.
ABOUT CATALENT CLINICAL SUPPLY SERVICES
Catalent is a global leader in clinical supply services, with comprehensive and flexible solutions for small molecules, biologics, and cell and gene therapies and integrated solutions to accelerate speed to clinic. Catalent offers a full range services including clinical supply management, comprehensive packaging solutions, comparator sourcing, cold chain storage and global distribution and specialized supply chain services including direct-to-patient and demand-led supply. With nine GMP clinical packaging facilities and over 50 strategically located depots on six continents combined with more than 25 years’ experience across thousands of studies in more than 80 countries, Catalent has the comprehensive services, global scale and expertise necessary to reliably supply clinical trials of all sizes and complexity anywhere in the world.
Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs approximately 14,000 people, including around 2,400 scientists and technicians, at more than 45 facilities, and in fiscal year 2020 generated over $3 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit www.catalent.com